Skip to main content

Advertisement

SpringerLink
Log in

Increased Circulating Levels of the Antiangiogenic Factor Endostatin in Early-Onset But Not Late-Onset Preeclampsia

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Changes in circulating angiogenic factors seem to play a key role in the pathogenesis of preeclampsia and it seems as if these changes are of greater importance in the pathogenesis of early-onset than of late-onset disease. Endostatin is a potent, broad spectrum antagonist of angiogenesis whose role in preeclampsia is poorly investigated. The aim of this study was to estimate whether circulating endostatin levels are altered in preeclampsia, and whether women with early-onset (before 32 weeks of gestation; n = 16) and late-onset (after 35 weeks of gestation; n = 19) preeclampsia differ in this regard. Women with early-onset, but not of late-onset preeclampsia had higher levels of endostatin than healthy pregnant women in corresponding lengths of gestation. The results of the study support the hypothesis that there is heterogeneity between early- and late-onset preeclampsia, with a stronger association between an altered angiogenic balance and early-onset than late-onset disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;(30 suppl A):S38–S42.

  2. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet. 1999;354(9181):788–789.

    Article  CAS  Google Scholar 

  3. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.

    Article  CAS  Google Scholar 

  4. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59:61–78.

    Article  CAS  Google Scholar 

  5. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in earlyand late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006;113(5):580–589.

    Article  CAS  Google Scholar 

  6. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond). 2004;106(4):377–382.

    Article  CAS  Google Scholar 

  7. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG. 2004;111(4):298–302.

    Article  Google Scholar 

  8. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.

    Article  CAS  Google Scholar 

  9. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–891.

    Article  CAS  Google Scholar 

  10. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007;109(6):1368–1374.

    Article  Google Scholar 

  11. Folkman J. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action. Exp Cell Res. 2006;312(5):594–607.

    Article  CAS  Google Scholar 

  12. O’Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88(2):277–285.

    Article  Google Scholar 

  13. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004;1654(1):13–22.

    CAS  PubMed  Google Scholar 

  14. Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem. 1999;274(17):11721–11726.

    Article  CAS  Google Scholar 

  15. Kim YM, Hwang S, Pyun BJ, et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem. 2002;277(31): 27872–27879.

    Article  CAS  Google Scholar 

  16. Wu P, Yonekura H, Li H, Nozaki I, Tomono Y, Naito I, et al. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem Biophys Res Commun. 2001;288(5):1149–1154.

    Article  CAS  Google Scholar 

  17. Pollheimer J, Bauer S, Huber A, Husslein P, Aplin JD, Knofler M. Expression pattern of collagen XVIII and its cleavage product, the angiogenesis inhibitor endostatin, at the fetal-maternal interface. Placenta. 2004;25(10):770–779.

    Article  CAS  Google Scholar 

  18. Mahmound RA, Abdel-Raouf M. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia. East Mediterr Health J. 2006;12(1–2):178–87.

    CAS  PubMed  Google Scholar 

  19. Hirtenlehner K, Pollheimer J, Lichtenberger C, et al. Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. J Soc Gynecol Investig. 2003;10(7): 412–417.

    Article  CAS  Google Scholar 

  20. Wathen KA, Ylikorkala O, Andersson S, Alfthan H, Stenman UH, Vuorela P. Maternal serum endostatin at gestational weeks 16–20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Acta Obstet Gynecol Scand. 2009;88(5):593–598.

    Article  CAS  Google Scholar 

  21. Wikland KA, Luo ZC, Niklasson A, Karlberg J. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr. 2002;91(7):739–754.

    Article  Google Scholar 

  22. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597–602.

    Article  CAS  Google Scholar 

  23. Ergun S, Kilic N, Wurmbach JH, et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis. 2001;4(3):193–206.

    Article  CAS  Google Scholar 

  24. Gupta AK, Gebhardt S, Hillermann R, Holzgreve W, Hahn S. Analysis of plasma elastase levels in early and late onset preeclampsia. Arch Gynecol Obstet. 2006;273(4):239–242.

    Article  CAS  Google Scholar 

  25. Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 1999;59(24):6052–6056.

    CAS  PubMed  Google Scholar 

  26. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors. 1995;12(3):235–243.

    Article  CAS  Google Scholar 

  27. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol. 1998;140(4): 947–959.

    Article  CAS  Google Scholar 

  28. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001;26(1):25–35.

    Article  CAS  Google Scholar 

  29. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999;155(1): 293–301.

    Article  Google Scholar 

  30. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy—its relevance for pre-eclampsia. Placenta. 1999;20(7):531–539.

    Article  CAS  Google Scholar 

  31. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol. 1993;100(10): 943–949.

    Article  CAS  Google Scholar 

  32. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol. 1997;104(2):235–240.

    Article  CAS  Google Scholar 

  33. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56–61.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Women’s and Children’s Health, Uppsala University, SE-751 85, Uppsala, Sweden

    Anna-Karin Wikström MD, PhD, Helena Åkerud MD, PhD & Matts Olovsson MD, PhD

  2. Departments of Medical Sciences, Uppsala University, Uppsala, Sweden

    Anders Larsson MD, PhD

Authors
  1. Anna-Karin Wikström MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anders Larsson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helena Åkerud MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matts Olovsson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna-Karin Wikström MD, PhD.

Additional information

This work was carried out at the Department of Women’s and Children’s Health, Uppsala University, Sweden.

This study was financially supported by the General Maternity Hospital Foundation, the Gillberg Foundation, the Swedish Society of Medicine, and the Uppsala-Orebro Regional Research Council.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wikström, AK., Larsson, A., Åkerud, H. et al. Increased Circulating Levels of the Antiangiogenic Factor Endostatin in Early-Onset But Not Late-Onset Preeclampsia. Reprod. Sci. 16, 995–1000 (2009). https://doi.org/10.1177/1933719109339348

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719109339348

Key words

Search

Navigation